Publication: Benefit of regional anaesthesia on postoperative pain following mastectomy: the influence of catastrophising
Issued Date
2019-08-01
Resource Type
ISSN
14716771
00070912
00070912
Other identifier(s)
2-s2.0-85063412105
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
British Journal of Anaesthesia. Vol.123, No.2 (2019), e293-e302
Suggested Citation
Nantthasorn Zinboonyahgoon, Kamen Vlassakov, Philipp Lirk, Tara Spivey, Tari King, Laura Dominici, Mehra Golshan, Gary Strichartz, Robert Edwards, Kristin Schreiber Benefit of regional anaesthesia on postoperative pain following mastectomy: the influence of catastrophising. British Journal of Anaesthesia. Vol.123, No.2 (2019), e293-e302. doi:10.1016/j.bja.2019.01.041 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51504
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Benefit of regional anaesthesia on postoperative pain following mastectomy: the influence of catastrophising
Other Contributor(s)
Abstract
© 2019 British Journal of Anaesthesia Background: Previous studies suggest that truncal regional anaesthesia (TRA), including techniques such as paravertebral block, may contribute significantly to analgesia after mastectomy. However, the severity and impact of postoperative pain varies markedly amongst individuals, making the identification of patients who would benefit most from TRA a potentially important step toward personalised perioperative care. Methods: In this prospective observational study, mastectomy patients (n=122) were recruited and systematically assessed for psychosocial characteristics including pain catastrophising before surgery, and either received preoperative TRA (n=57) or no block (n=65). Results: Age, baseline pain, and psychosocial traits did not differ between these groups. TRA was associated with lower overall pain scores and opioid consumption perioperatively, with a larger proportion of patients without block (50% vs 28%) reporting moderate-severe pain (more than three/10) on the day of surgery. Mixed model analysis of variance revealed a significant interaction between catastrophising and TRA, such that amongst patients with high baseline catastrophising, TRA was associated with substantially lower pain severity score (58% lower), while amongst patients with low baseline catastrophising, TRA was associated with only 18% lower pain severity. At 2 weeks, this interaction between baseline catastrophising and TRA was also observed when examining surgical pain burden, with higher baseline catastrophising patients who had received TRA reporting lower pain and less frequent opioid use (40% vs 70% of patients). Conclusions: TRA provided immediate analgesic benefit for patients undergoing mastectomy on the day of surgery, but this effect appeared more pronounced and sustained amongst patients with higher baseline catastrophising. Clinical trial registration: NCT 02329574.